Own Medibank shares? Here’s what to watch over the coming months

What are the key dates for Medibank in 2022?

| More on:
ASX share price movement represented by doctor pressing digitised screen with array of icons including one entitled health insurance

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Medibank shares slide 0.47% to $3.165 
  • The heavy falls on the ASX have attributed to the company's share price decline 
  • Medibank announced its key dates for investors to pencil in for the remainder of 2022 

The Medibank Private Ltd (ASX: MPL) share price is heading south on Thursday following a broader market slump.

This comes amid the private health insurer announcing some key dates for its 2022 calendar this morning.

At the time of writing, Medibank shares are fetching at $3.165, down 0.47%. In comparison, the S&P/ASX 200 Index (ASX: XJO) is struggling throughout the day to trade at 6,977.9 points, down 1.23%.

What’s Medibank’s agenda for the remainder of 2022?

With the year almost halfway done, Australia’s premier health insurance provider, Medibank released its key dates for 2022.

The most important date in the near term is on 18 August, when the company will deliver its full year results.

In addition to its 12-month performance report, a 2022 final dividend will also be announced by the board.

The ex-dividend date is scheduled to occur the following month on 7 September. This is when investors must have purchased Medibank shares to be eligible for payment of the upcoming dividend.

The date for when shareholders will receive the final dividend payment is set for 29 September. 

For context, Medibank returned to shareholders a fully-franked final dividend payment of 6.9 cents per share for FY21.

Lastly, the company will hold its 2022 annual general meeting (AGM) on 16 November. This will likely recap the events over the last 12 months, as well as the near-term outlook for the private health insurer.

Medibank share price snapshot

Since this time last year, the Medibank share price has travelled in circles to post a gain of around 5%.

When looking at year to date, its shares have traversed the other way, down 5%.

Based on today’s price, Medibank commands a market capitalisation of roughly $8.73 billion.

The company currently has a trailing dividend yield of 4.10% and a price-to-earnings (P/E) ratio of 20.06.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Two researchers discussing results of a study with each other.
Healthcare Shares

Here’s how ASX 200 healthcare shares performed in June

Healthcare shares were a tad ill in June.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Healthcare Shares

What’s the outlook for the CSL share price in July?

We take a look at what the experts are saying about the biotech company's shares.

Read more »

Photo of a group of scientists cheering while working in a lab as the Race Oncology share price skyrockets today on positive study results
Healthcare Shares

Why is the Race Oncology share price soaring 13% today?

New trial results have excited ASX investors.

Read more »

Rising arrow on a blue graph symbolising a rising share price.
Healthcare Shares

Starphama share price lunges 5% on product relaunch

Early support for Starphama on Thursday has it off to a great start.

Read more »

Man with rocket wings which have flames coming out of them.
Healthcare Shares

Why is the Paradigm share price rocketing 20% higher today?

The Paradigm share price is having a very strong day...

Read more »

A businessman presents a company annual report in front of a group seated at a table
Healthcare Shares

Own Immutep shares? Here are 3 takeaways from the company’s investor update

Investors were mute to the update.

Read more »

A health professional wearing a stethoscope and scrubs shrugs with uncertainty.
Healthcare Shares

Has CSL been growing its dividend?

Is the biotech giant still increasing its dividends in a post-COVID world?

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Healthcare Shares

Why is the 4DMedical share price exploding 40% today?

4DMedical signed a three-year, nationwide contract with I-MED Radiology Network.

Read more »